Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from Treatment.com International ( (TSE:TRUE) ).
Treatment.com AI Inc. has engaged i2i Marketing Group to enhance its marketing and investor awareness through digital and online advertising for six months, starting January 2025, with a budget of USD$200,000. This strategic move aims to strengthen Treatment’s market presence and outreach, potentially impacting its operational effectiveness and stakeholder engagement positively.
More about Treatment.com International
Treatment.com AI Inc. is a healthcare company that leverages artificial intelligence and clinical practices to address inefficiencies within the healthcare sector. The company has developed the Global Library of Medicine (GLM), a comprehensive AI engine intended to assist healthcare professionals by providing accurate clinical information and reducing administrative tasks, thereby promoting health equity and inclusion for underserved communities.
YTD Price Performance: 43.64%
Average Trading Volume: 5,608
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $23.16M
See more data about TRUE stock on TipRanks’ Stock Analysis page.
